Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242339 (
dyslipidemia
)
13,927
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Proteins secreted from adipose tissue are increasingly recognized to play an important role in the regulation of glucose metabolism. However, much less is known about their effect on lipid metabolism. The
fasting-induced adipose factor
(
FIAF
/angiopoietin-like protein 4/peroxisome proliferator-activated receptor gamma angiopoietin-related protein) was previously identified as a target of hypolipidemic fibrate drugs and insulin-sensitizing thiazolidinediones. Using transgenic mice that mildly overexpress
FIAF
in peripheral tissues we show that
FIAF
is an extremely powerful regulator of lipid metabolism and adiposity.
FIAF
overexpression caused a 50% reduction in adipose tissue weight, partly by stimulating fatty acid oxidation and uncoupling in fat. In addition,
FIAF
overexpression increased plasma levels of triglycerides, free fatty acids, glycerol, total cholesterol, and high density lipoprotein (HDL)-cholesterol. Functional tests indicated that
FIAF
overexpression severely impaired plasma triglyceride clearance but had no effect on very low density lipoprotein production. The effects of
FIAF
overexpression were amplified by a high fat diet, resulting in markedly elevated plasma and liver triglycerides, plasma free fatty acids, and plasma glycerol levels, and impaired glucose tolerance in
FIAF
transgenic mice fed a high fat diet. Remarkably, in mice the full-length form of
FIAF
was physically associated with HDL, whereas truncated
FIAF
was associated with low density lipoprotein. In human both full-length and truncated
FIAF
were associated with HDL. The composite data suggest that via physical association with plasma lipoproteins,
FIAF
acts as a powerful signal from fat and other tissues to prevent fat storage and stimulate fat mobilization. Our data indicate that disturbances in
FIAF
signaling might be involved in
dyslipidemia
.
...
PMID:The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. 1627 64